{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T17:42:43Z","timestamp":1711129363274},"reference-count":63,"publisher":"BMJ","issue":"Supplement 2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thorax"],"published-print":{"date-parts":[[1997,4,1]]},"DOI":"10.1136\/thx.52.2008.s64","type":"journal-article","created":{"date-parts":[[2010,1,11]],"date-time":"2010-01-11T19:40:22Z","timestamp":1263238822000},"page":"S64-S68","source":"Crossref","is-referenced-by-count":9,"title":["Nebulised bronchodilators, corticosteroids, and rhDNase in adult patients with cystic fibrosis"],"prefix":"10.1136","volume":"52","author":[{"given":"S. P.","family":"Conway","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1542\/peds.50.2.291","article-title":"Early detection of pulmonary function abnormalities in cystic fibrosis","volume":"50","author":"Lamarre, A.; Reilly, B.J.; Bryan, A.C.; Levison, H.","year":"1972","unstructured":"Lamarre A, Reilly BJ, Bryan AC, Levison H. Early detection of pulmonary function abnormalities in cystic fibrosis. Pediatrics 1972;50:291\u20138.","journal-title":"Pediatrics"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0022-3476(78)81070-1","article-title":"Bronchial hyperreactivity in cystic fibrosis and asthma","volume":"93","author":"Mitchell, I.; Corey, M.; Woenne, R.; Krastins, I.R.B.; Levison, H.","year":"1978","unstructured":"Mitchell I, Corey M, Woenne R, Krastins IRB, Levison H. Bronchial hyperreactivity in cystic fibrosis and asthma. J Pediatr 1978;93:744\u20138.","journal-title":"J Pediatr"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/ppul.1950080311","article-title":"Lung disease in cystic fibrosis \u2013 an updated concept","volume":"8","author":"Zach, M.S.","year":"1990","unstructured":"Zach MS. Lung disease in cystic fibrosis \u2013 an updated concept. Pediatr Pulmonol 1990;8:188\u2013202.","journal-title":"Pediatr Pulmonol"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1164\/arrd.1985.131.4.537","article-title":"Bronchodilators increase airway instability in cystic fibrosis","volume":"131","author":"Zach, M.S.; Oberwaldner, B.; Forch, E.G.; Polgar, G.","year":"1985","unstructured":"Zach MS, Oberwaldner B, Forch EG, Polgar G. Bronchodilators increase airway instability in cystic fibrosis. Am Rev Respir Dis 1985;131:537\u201343.","journal-title":"Am Rev Respir Dis"},{"key":"ref_5","first-page":"555","article-title":"Therapeutic management of cystic fibrosis","volume":"4","author":"Kuhn, R.J.; Nahata, M.C.","year":"1985","unstructured":"Kuhn RJ, Nahata MC. Therapeutic management of cystic fibrosis. Clin Pharmacol 1985;4:555\u201365.","journal-title":"Clin Pharmacol"},{"key":"ref_6","first-page":"226","article-title":"Lung function in cystic fibrosis. Acute effect of salbutamol","volume":"40","author":"Svenonius, E.; Arborelius, M.; Kautto, R.; Kornfalt, R.; Londberg, T.","year":"1987","unstructured":"Svenonius E, Arborelius M, Kautto R, Kornfalt R, Londberg T. Lung function in cystic fibrosis. Acute effect of salbutamol. Respiration 1987;40:226\u201332.","journal-title":"Respiration"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1378\/chest.27.6.654","article-title":"Pulmonary manifestations of fibrocystic disease of the pancreas","volume":"27","author":"PA, Di Sant\u2019Agnese","year":"1955","unstructured":"Di Sant\u2019Agnese PA. Pulmonary manifestations of fibrocystic disease of the pancreas. Dis Chest 1955;27:654\u201367.","journal-title":"Dis Chest"},{"key":"ref_8","first-page":"389","article-title":"Severe respiratory disease in infants with cystic fibrosis","volume":"30","author":"Lloyd-Still, JR, Khaw; KT, Shwachman; H.","year":"1974","unstructured":"Lloyd-Still JR, Khaw KT, Shwachman H. Severe respiratory disease in infants with cystic fibrosis. Pediatrics 1974;30: 389\u201396.","journal-title":"Pediatrics"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0021-8707(60)90037-X","article-title":"Evidence of allergy in patients with cystic fibrosis of the pancreas","volume":"31","author":"TE, Van Metre; RE, Hooke; LE, Gibson; WL, Winkenwerder","year":"1960","unstructured":"Van Metre TE, Hooke RE, Gibson LE, Winkenwerder WL. Evidence of allergy in patients with cystic fibrosis of the pancreas. J Allergy 1960;31:141\u201350.","journal-title":"J Allergy"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1183\/09031936.93.05091089","article-title":"Comparison of nebulised and intravenous terbutaline during exacerbations of pulmonary infection in patients with cystic fibrosis","volume":"5","author":"Finnegan, M.J.; Hughes, D.V.; Hodson, M.E.","year":"1992","unstructured":"Finnegan MJ, Hughes DV, Hodson ME. Comparison of nebulised and intravenous terbutaline during exacerbations of pulmonary infection in patients with cystic fibrosis. Eur Respir J 1992;5:1089\u201391.","journal-title":"Eur Respir J"},{"key":"ref_11","first-page":"52","article-title":"Pulmonary physiology","author":"Levison, H.; Tabachnik, E.","year":"1983","unstructured":"Levison H, Tabachnik E. Pulmonary physiology. In: Hodson ME, Norman AP, Batten JC, eds. Cystic fibrosis. London: Bailliere Tindall, 1983: 52\u201381."},{"key":"ref_12","first-page":"889","article-title":"A longitudinal study of bronchodilator responsiveness in cystic fibrosis","volume":"131","author":"Hordvik, N.L.; Kernig, P.; Morris, D.; Kreutz, C.; Barbero, G.J.","year":"1985","unstructured":"Hordvik NL, Kernig P, Morris D, Kreutz C, Barbero GJ. A longitudinal study of bronchodilator responsiveness in cystic fibrosis. Am Rev Respir Dis 1985;131:889\u201393.","journal-title":"Am Rev Respir Dis"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1152\/jappl.1980.48.5.868","article-title":"Beta-adrenergic stimulation of respiratory ciliary activity","volume":"48","author":"Verdugo, P.; Johnson, N.T.; Taur, P.Y.","year":"1980","unstructured":"Verdugo P, Johnson NT, Taur PY. Beta-adrenergic stimulation of respiratory ciliary activity. J Appl Physiol 1980; 48:868\u201371.","journal-title":"J Appl Physiol"},{"key":"ref_14","first-page":"733","article-title":"Tracheal mucociliary transport in cystic fibrosis and its stimulation by terbutaline","volume":"111","author":"Wood, R.E.; Wanner, A.; Hirsch, J.; Farrel, P.M.","year":"1975","unstructured":"Wood RE, Wanner A, Hirsch J, Farrel PM. Tracheal mucociliary transport in cystic fibrosis and its stimulation by terbutaline. Am Rev Respir Dis 1975;111:733\u20138.","journal-title":"Am Rev Respir Dis"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0022-3476(73)80085-X","article-title":"The variable effect of a bronchodilating agent on pulmonary function in cystic fibrosis","volume":"82","author":"Landau, L.I.; Phelan, P.D.","year":"1973","unstructured":"Landau LI, Phelan PD. The variable effect of a bronchodilating agent on pulmonary function in cystic fibrosis. J Pediatr 1973;82:863\u20138.","journal-title":"J Pediatr"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1542\/peds.58.5.740","article-title":"The paradoxical effect of adrenergic and methylxanthine drugs in cystic fibrosis","volume":"58","author":"Shapiro, G.G.; Bamman, J.; Kanarele, P.; Bierman, C.W.","year":"1976","unstructured":"Shapiro GG, Bamman J, Kanarele P, Bierman CW. The paradoxical effect of adrenergic and methylxanthine drugs in cystic fibrosis. Pediatrics 1976;58:740\u20133.","journal-title":"Pediatrics"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1136\/thx.35.11.807","article-title":"Atopy and bronchial reactivity in older patients with cystic fibrosis","volume":"35","author":"Tobin, M.J.; Maguire, O.; Reen, D.; Tempany, E.; Fitzgerald, M.X.","year":"1980","unstructured":"Tobin MJ, Maguire O, Reen D, Tempany E, Fitzgerald MX. Atopy and bronchial reactivity in older patients with cystic fibrosis. Thorax 1980;35:807\u201313.","journal-title":"Thorax"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1378\/chest.94.2.360","article-title":"Airway hyperreactivity in cystic fibrosis: clinical correlates and possible effects on the course of the disease","volume":"94","author":"Eggleston, P.A.; Rosenstein, B.J.; Stackhouse, C.M.; Alexander, M.E.","year":"1988","unstructured":"Eggleston PA, Rosenstein BJ, Stackhouse CM, Alexander ME. Airway hyperreactivity in cystic fibrosis: clinical correlates and possible effects on the course of the disease. Chest 1988;94:360\u20135.","journal-title":"Chest"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1378\/chest.99.5.1088","article-title":"A controlled trial of long term bronchodilator therapy in cystic fibrosis","volume":"99","author":"Eggleston, P.A.; Rosenstein, B.J.; Stackhouse, C.M.; Mellitis, D.; Baumgardner, R.A.","year":"1991","unstructured":"Eggleston PA, Rosenstein BJ, Stackhouse CM, Mellitis D, Baumgardner RA. A controlled trial of long term bronchodilator therapy in cystic fibrosis. Chest 1991;99:1088\u201392.","journal-title":"Chest"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1183\/09031936.93.05091083","article-title":"Bronchial vagal tone and responsiveness to histamine, exercise and bronchodilators in adult patients with cystic fibrosis","volume":"5","author":"van Haren EHJ; JWJ, Lammers; J, Festen; van Herwaarden CLA","year":"1992","unstructured":"van Haren EHJ, Lammers JWJ, Festen J, van Herwaarden CLA. Bronchial vagal tone and responsiveness to histamine, exercise and bronchodilators in adult patients with cystic fibrosis. Eur Respir J 1992;5:1083\u20138.","journal-title":"Eur Respir J"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2222.1977.tb01448.x","article-title":"Bronchial reactivity to inhaled histamine: a method and clinical survey","volume":"7","author":"Cockcroft, D.W.; Killiand, N.; Mellon, J.J.A.; Hargreave, F.E.","year":"1977","unstructured":"Cockcroft DW, Killiand N, Mellon JJA, Hargreave FE. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 1977;7:235\u201343.","journal-title":"Clin Allergy"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1378\/chest.95.4.861","article-title":"The inhaled bronchodilators ipratropium bromide and metaproterenol in adults with cystic fibrosis","volume":"95","author":"Weintraub, S.J.; Eschenbacher, W.L.","year":"1989","unstructured":"Weintraub SJ, Eschenbacher WL. The inhaled bronchodilators ipratropium bromide and metaproterenol in adults with cystic fibrosis. Chest 1989;95:861\u20134.","journal-title":"Chest"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1183\/09031936.93.04030301","article-title":"Bronchodilator response in adult patients with cystic fibrosis: effects on large and small airways","volume":"4","author":"van Haren EHJ; JWJ, Lammers; J, Festen; van Herwaarden CLA","year":"1991","unstructured":"van Haren EHJ, Lammers JWJ, Festen J, van Herwaarden CLA. Bronchodilator response in adult patients with cystic fibrosis: effects on large and small airways. Eur Respir J 1991;4:301\u20137.","journal-title":"Eur Respir J"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ppul.1950040404","article-title":"Airway obstruction and airway wall instability in cystic fibrosis: the isolated and combined effect of theophylline and sympathomimetics","volume":"4","author":"Eber, E.; Oberwaldner, B.; Zach, M.S.","year":"1988","unstructured":"Eber E, Oberwaldner B, Zach MS. Airway obstruction and airway wall instability in cystic fibrosis: the isolated and combined effect of theophylline and sympathomimetics. Pediatr Pulmonol 1988;4:205\u201312.","journal-title":"Pediatr Pulmonol"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/adc.56.6.455","article-title":"Variability of airways hyperreactivity and allergy in cystic fibrosis","volume":"56","author":"Holzer, F.J.; Olinsky, A.; Phelan, P.D.","year":"1981","unstructured":"Holzer FJ, Olinsky A, Phelan PD. Variability of airways hyperreactivity and allergy in cystic fibrosis. Arch Dis Child 1981;56:455\u20139.","journal-title":"Arch Dis Child"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1378\/chest.99.5.1061","article-title":"Long-term inhaled bronchodilator therapy in cystic fibrosis","volume":"99","author":"Orenstein, D.M.","year":"1991","unstructured":"Orenstein DM. Long-term inhaled bronchodilator therapy in cystic fibrosis. Chest 1991;99:1061.","journal-title":"Chest"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/thx.35.7.531","article-title":"Response to aerosol salbutamol, SCH 1000, and placebo","volume":"35","author":"Kattan, M.; Mansell, A.; Levison, H.; Corey, M.; Krastins, I.R.B.","year":"1980","unstructured":"Kattan M, Mansell A, Levison H, Corey M, Krastins IRB. Response to aerosol salbutamol, SCH 1000, and placebo. Thorax 1980;35:531\u20135.","journal-title":"Thorax"},{"key":"ref_28","first-page":"277","article-title":"The influence of ipratropium bromide on pulmonary function in patients with cystic fibrosis","volume":"44","author":"Wiebecke, W.; Poynter, A.; Montgomery, M.; Pagtakhan, R.","year":"1990","unstructured":"Wiebecke W, Poynter A, Montgomery M, Pagtakhan R. The influence of ipratropium bromide on pulmonary function in patients with cystic fibrosis. Pneumologie 1990;44: 277\u20138.","journal-title":"Pneumologie"},{"key":"ref_29","first-page":"317","article-title":"within-subject comparison of albuterol sulphate vs placebo on lung function in hospitalised patients with cystic fibrosis","volume":"10","author":"Hordvik, N.; Sammut, P.; Judy, G.; Strizek, S.; Double-blind, Colombo J.; placebo-control","year":"1994","unstructured":"Hordvik N, Sammut P, Judy G, Strizek S, Colombo J. Double-blind, placebo-control, within-subject comparison of albuterol sulphate vs placebo on lung function in hospitalised patients with cystic fibrosis. Pediatr Pulmonol 1994;10(Suppl):A317.","journal-title":"Pediatr Pulmonol"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0022-3476(05)80927-8","article-title":"Acute bronchodilator response to a combination of beta-adrenergic and anticholinergic agents in patients with cystic fibrosis","volume":"120","author":"Sanchez, I.; Holbrow, J.; Chernick, V.","year":"1992","unstructured":"Sanchez I, Holbrow J, Chernick V. Acute bronchodilator response to a combination of beta-adrenergic and anticholinergic agents in patients with cystic fibrosis. J Pediatr 1992;120:486\u20138.","journal-title":"J Pediatr"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1164\/ajrccm.149.3.8118635","article-title":"Effect of salbutamol on gas compression in cystic fibrosis and asthma","volume":"149","author":"Desmond, K.J.; Demizio, D.L.; Allen, P.D.; MacDonald, N.D.; Coates, A.L.","year":"1994","unstructured":"Desmond KJ, Demizio DL, Allen PD, MacDonald ND, Coates AL. Effect of salbutamol on gas compression in cystic fibrosis and asthma. Am J Respir Crit Care Med 1994;149:673\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ppul.1950080105","article-title":"Changes in air flow obstruction and oxygen saturation in response to exercise and bronchodilators in cystic fibrosis","volume":"8","author":"McFarlane, P.I.; Heaf, D.","year":"1990","unstructured":"McFarlane PI, Heaf D. Changes in air flow obstruction and oxygen saturation in response to exercise and bronchodilators in cystic fibrosis. Pediatr Pulmonol 1990;8:4\u201311.","journal-title":"Pediatr Pulmonol"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/ppul.1950090204","article-title":"Longitudinal response of pulmonary function to bronchodilators in cystic fibrosis","volume":"9","author":"Pattishall, E.N.","year":"1990","unstructured":"Pattishall EN. Longitudinal response of pulmonary function to bronchodilators in cystic fibrosis. Pediatr Pulmonol 1990; 9:80\u20135.","journal-title":"Pediatr Pulmonol"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/ppul.1950150503","article-title":"Increased physiological dead space during exercise after bronchodilation in cystic fibrosis","volume":"15","author":"Kusenbach, G.; Friedrichs, F.; Skopnik, H.; Heimann, G.","year":"1993","unstructured":"Kusenbach G, Friedrichs F, Skopnik H, Heimann G. Increased physiological dead space during exercise after bronchodilation in cystic fibrosis. Pediatr Pulmonol 1993; 15:273\u20138.","journal-title":"Pediatr Pulmonol"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF02914538","article-title":"Inflammation in the lung in cystic fibrosis","volume":"9","author":"Berger, M.","year":"1991","unstructured":"Berger M. Inflammation in the lung in cystic fibrosis. Clin Rev Allergy 1991;9:119\u201342.","journal-title":"Clin Rev Allergy"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1164\/ajrccm.150.2.8049828","article-title":"Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation","volume":"150","author":"Konstan, M.W.; Hilliard, K.A.; Norvell, T.M.; Berger, M.","year":"1994","unstructured":"Konstan MW, Hilliard KA, Norvell TM, Berger M. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med 1994;150:448\u201354.","journal-title":"Am J Respir Crit Care Med"},{"key":"ref_37","first-page":"686","article-title":"Alternate day prednisolone reduces morbidity and improves pulmonary function in cystic fibrosis","volume":"ii:","author":"Auerbach, H.S.; Kirkpatrick, J.A.; Williams, M.; Colten, H.R.","year":"1985","unstructured":"Auerbach HS, Kirkpatrick JA, Williams M, Colten HR. Alternate day prednisolone reduces morbidity and improves pulmonary function in cystic fibrosis. Lancet 1985; ii:686\u20138.","journal-title":"Lancet"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1542\/peds.87.2.245","article-title":"Risks of alternate day prednisolone in patients with cystic fibrosis","volume":"87","author":"Rosenstein, B.J.; Eigen, H.","year":"1991","unstructured":"Rosenstein BJ, Eigen H. Risks of alternate day prednisolone in patients with cystic fibrosis. Pediatrics 1991;87:245\u20136.","journal-title":"Pediatrics"},{"key":"ref_39","first-page":"231","article-title":"Effect of inhaled corticosteroids on lung function in cystic fibrosis patients","volume":"17","author":"Nikolaizik, W.H.; Schoni, M.H.","year":"1993","unstructured":"Nikolaizik WH, Schoni MH. Effect of inhaled corticosteroids on lung function in cystic fibrosis patients. Eur Respir J 1993;6(Suppl 17):231S (abstract).","journal-title":"Eur Respir J"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0954-6111(95)90249-X","article-title":"The effects of the inhaled corticosteroid budesonide on lung function and bronchial hyperresponsiveness in adult patients with cystic fibrosis","volume":"89","author":"van Haren EHJ; JWJ, Lammers; J, Festen; HGM, Heijerman; CAR, Groot; van Herwaarden CLA","year":"1995","unstructured":"van Haren EHJ, Lammers JWJ, Festen J, Heijerman HGM, Groot CAR, van Herwaarden CLA. The effects of the inhaled corticosteroid budesonide on lung function and bronchial hyperresponsiveness in adult patients with cystic fibrosis. Respir Med 1995;89:209\u201314.","journal-title":"Respir Med"},{"key":"ref_41","first-page":"395","article-title":"Inhaled steroid treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection","volume":"10","author":"Bisgarrd, H.; Neilsen, K.G.; Skov, M.; Mosfeldt, E.; Bjerre, B.; Pedersen, S.S.","year":"1994","unstructured":"Bisgarrd H, Neilsen KG, Skov M, Mosfeldt E, Bjerre B, Pedersen SS, et al. Inhaled steroid treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. Pediatr Pulmonol 1994;10(Suppl):A395.","journal-title":"Pediatr Pulmonol"},{"key":"ref_42","first-page":"396","article-title":"Mid-term efficacy of inhaled flunisolide associated with albuterol in cystic fibrosis","volume":"10","author":"Romano, L.; Antonelli, M.; Castello, M.; de Candussio, G.; Diamanti, S.; Manzoni, P.","year":"1994","unstructured":"Romano L, Antonelli M, Castello M, de Candussio G, Diamanti S, Manzoni P, et al. Mid-term efficacy of inhaled flunisolide associated with albuterol in cystic fibrosis. Pediatr Pulmonol 1994;10(Suppl):A396.","journal-title":"Pediatr Pulmonol"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1183\/09031936.93.01010022","article-title":"Moderately severe chronic airflow obstruction. Can corticosteroids slow down obstruction?","volume":"1","author":"Postma, D.S.; Peters, I.; Steenhuis, E.J.; Sluiter, H.J.","year":"1988","unstructured":"Postma DS, Peters I, Steenhuis EJ, Sluiter HJ. Moderately severe chronic airflow obstruction. Can corticosteroids slow down obstruction? Eur Respir J 1988;1:22\u20136.","journal-title":"Eur Respir J"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"770","DOI":"10.7326\/0003-4819-118-10-199305150-00003","article-title":"Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids","volume":"118","author":"Dompeling, E.; van Schayck, C.P.; van Grunseven, P.M.; van Herwaarden, C.L.A.; Akkermans, R.; Molena, J.","year":"1993","unstructured":"Dompeling E, van Schayck CP, van Grunseven PM, van Herwaarden CLA, Akkermans R, Molena J, et al. Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. Ann Intern Med 1993; 118:770\u20138.","journal-title":"Ann Intern Med"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJM199211123272003","article-title":"A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease","volume":"327","author":"Kerstjens, H.A.M.; Brand, P.L.P.; Hughes, M.D.; Robinson, J.; Postma, D.S.; Sluiter, H.J.","year":"1992","unstructured":"Kerstjens HAM, Brand PLP, Hughes MD, Robinson J, Postma DS, Sluiter HJ, et al. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. N Engl J Med 1992; 327:1413\u20139.","journal-title":"N Engl J Med"},{"key":"ref_46","first-page":"56","article-title":"Severe chronic airflow obstruction: can corticosteroid slow down progression?","volume":"67","author":"Postma, D.S.; Steenhuis, E.J.; van der Weelel, T.; Sluiter, H.J.","year":"1985","unstructured":"Postma DS, Steenhuis EJ, van der Weelel T, Sluiter HJ. Severe chronic airflow obstruction: can corticosteroid slow down progression? Eur Respir J Dis 1985;67:56\u201364.","journal-title":"Eur Respir J Dis"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1164\/ajrccm\/137.1.44","article-title":"Dosage and time effects of inhaled budesonide on bronchial hyperreactivity","volume":"137","author":"Kraan, J.; Koeter, G.H.; van der Mark, T.W.; Boorsma, M.; Kukler, J.; Sluiter, H.J.","year":"1988","unstructured":"Kraan J, Koeter GH, van der Mark TW, Boorsma M, Kukler J, Sluiter HJ, et al. Dosage and time effects of inhaled budesonide on bronchial hyperreactivity. Am Rev Respir Dis 1988;137:44\u20138.","journal-title":"Am Rev Respir Dis"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/thx.45.2.118","article-title":"Time course of response to oral and inhaled corticosteroids in nonasthmatic chronic airflow obstruction","volume":"45","author":"Weird, D.C.; Robertson, A.S.; Gobe, R.I.; Burge, P.S.","year":"1990","unstructured":"Weird DC, Robertson AS, Gobe RI, Burge PS. Time course of response to oral and inhaled corticosteroids in nonasthmatic chronic airflow obstruction. Thorax 1990;45: 118\u201321.","journal-title":"Thorax"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1183\/09031936.93.03010019","article-title":"The origin of DNA associated with mucus glycoproteins in cystic fibrosis sputum","volume":"3","author":"Lethem, M.I.; James, S.L.; Marriott, C.; Burke, J.F.","year":"1990","unstructured":"Lethem MI, James SL, Marriott C, Burke JF. The origin of DNA associated with mucus glycoproteins in cystic fibrosis sputum. Eur Respir J 1990;3:19\u201323.","journal-title":"Eur Respir J"},{"key":"ref_50","first-page":"9188","article-title":"Recombinant human DNase 1 reduces the viscosity of","volume-title":"cystic fibrosis sputum. Proc Natl Acad Sci","volume":"87","author":"Shak, S.; Capon, D.J.; Hellmiss, R.; Masters, S.A.; Baker, C.L.","year":"1990","unstructured":"Shak S, Capon DJ, Hellmiss R, Masters SA, Baker CL. Recombinant human DNase 1 reduces the viscosity of cystic fibrosis sputum. Proc Natl Acad Sci USA 1990;87: 9188\u201392."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/jac\/22.4.483","article-title":"The binding of anti-pseudomonal antibiotics to macromolecules from cystic fibrosis sputum","volume":"22","author":"Ramphal, R.; Lhermitte, M.; Filliat, M.; Roussel, P.","year":"1988","unstructured":"Ramphal R, Lhermitte M, Filliat M, Roussel P. The binding of anti-pseudomonal antibiotics to macromolecules from cystic fibrosis sputum. J Antimicrob Chemother 1988;22: 483\u201390.","journal-title":"J Antimicrob Chemother"},{"issue":"384","key":"ref_52","first-page":"1947","article-title":"Recombinant human DNase 1 greatly potentiates the bactericidal activity of tobramycin in sputum","volume":"40","author":"Maas, K.; Shak, S.; Smith, A.L.","year":"1992","unstructured":"Maas K, Shak S, Smith AL. Recombinant human DNase 1 greatly potentiates the bactericidal activity of tobramycin in sputum. Clin Res 1992;40:384A. 53 Aitken ML, Burke W, MacDonald G, Shak S, Montgomery AB, Smith A. Effect of inhaled recombinant human DNase on pulmonary function in normal and cystic fibrosis patients: phase I. JAMA 1992;267:1947\u201351.","journal-title":"Clin Res; Effect of inhaled recombinant human DNase on pulmonary function in normal and cystic fibrosis patients: phase I"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1056\/NEJM199203193261207","article-title":"A preliminary study of aerosolised recombinant human deoxyribose 1 in the sputum of cystic fibrosis","volume":"326","author":"Hubbard, R.C.; McElvaney, N.G.; Birrer, P.; Shak, S.; Robinson, W.W.; Jolley, C.","year":"1992","unstructured":"Hubbard RC, McElvaney NG, Birrer P, Shak S, Robinson WW, Jolley C, et al. A preliminary study of aerosolised recombinant human deoxyribose 1 in the sputum of cystic fibrosis. N Engl J Med 1992;326:812\u20135.","journal-title":"N Engl J Med"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1164\/ajrccm\/148.1.145","article-title":"Efficacy and safety of short-term administration of aerosolised recombinant human deoxyribonuclease in patients with cystic fibrosis","volume":"148","author":"Ramsey, B.W.; Astley, S.J.; Aitken, M.L.; Burke, W.; Colin, A.A.; Dorkin, H.L.","year":"1993","unstructured":"Ramsey BW, Astley SJ, Aitken ML, Burke W, Colin AA, Dorkin HL, et al. Efficacy and safety of short-term administration of aerosolised recombinant human deoxyribonuclease in patients with cystic fibrosis. Am Rev Respir Dis 1993;148:145\u201351.","journal-title":"Am Rev Respir Dis"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0140-6736(93)92297-7","article-title":"Efficacy and safety of short-term administration of aerosolised recombinant human DNase 1 in adults with stable stage cystic fibrosis","volume":"342","author":"Ranasinha, C.; Assoufi, V.; Shak, S.; Christiansen, D.; Fuchs, H.; Empey, D.","year":"1993","unstructured":"Ranasinha C, Assoufi V, Shak S, Christiansen D, Fuchs H, Empey D, et al. Efficacy and safety of short-term administration of aerosolised recombinant human DNase 1 in adults with stable stage cystic fibrosis. Lancet 1993; 342:199\u2013202.","journal-title":"Lancet"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJM199409083311003","article-title":"Effects of aerosolised recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis","volume":"331","author":"Fuchs, H.J.; Borowitz, D.S.; Christiansen, D.H.; Morris, E.M.; Nash, M.L.; Ramsey, B.W.","year":"1994","unstructured":"Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, et al. Effects of aerosolised recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. N Engl J Med 1994;331:637\u201342.","journal-title":"N Engl J Med"},{"key":"ref_57","article-title":"Long-term follow-up of phase III rhDNase trial. North American Cystic Fibrosis Conference","author":"Rosenstein, B.J.; Johnson, C.A.C.","year":"1994","unstructured":"Rosenstein BJ, Johnson CAC. Long-term follow-up of phase III rhDNase trial. North American Cystic Fibrosis Conference, Orlando, 1994."},{"key":"ref_58","first-page":"154","article-title":"The DNase multicentre study group and Genentech staff. A phase II double-blind multicentre study of the safety and efficacy of aerosolised recombinant human DNase 1 in hospitalised patients with cystic fibrosis experiencing acute pulmonary exacerbations","volume":"9","author":"Wilmott, R.","year":"1993","unstructured":"Wilmott R. The DNase multicentre study group and Genentech staff. A phase II double-blind multicentre study of the safety and efficacy of aerosolised recombinant human DNase 1 in hospitalised patients with cystic fibrosis experiencing acute pulmonary exacerbations. Pediatr Pulmonol 1993;9(Suppl):154.","journal-title":"Pediatr Pulmonol"},{"key":"ref_59","first-page":"157","article-title":"Report on a multicentre study using aerosolised recombinant human DNase 1 in the treatment of cystic fibrosis patients with severe pulmonary disease","volume":"9","author":"Shah, P.L.; Scott, S.F.; Hodson, M.E.","year":"1993","unstructured":"Shah PL, Scott SF, Hodson ME. Report on a multicentre study using aerosolised recombinant human DNase 1 in the treatment of cystic fibrosis patients with severe pulmonary disease. Pediatr Pulmonol 1993;9(Suppl):157\u2013 8.","journal-title":"Pediatr Pulmonol"},{"key":"ref_60","article-title":"A multicentre double-blind placebo controlled study to evaluate the safety and efficacy of aerosolised rhDNase therapy in patients with cystic fibrosis who have advanced lung disease","author":"Johnson, C.","year":"1994","unstructured":"Johnson C. A multicentre double-blind placebo controlled study to evaluate the safety and efficacy of aerosolised rhDNase therapy in patients with cystic fibrosis who have advanced lung disease. North American Cystic Fibrosis Conference, Orlando, 1994.","journal-title":"North American Cystic Fibrosis Conference, Orlando"},{"key":"ref_61","first-page":"404","article-title":"Consensus conference: practical application of pulmozyme","volume":"17","author":"Ramsey, B.W.","year":"1994","unstructured":"Ramsey BW. Consensus conference: practical application of pulmozyme. Pediatr Pulmonol 1994;17:404\u20138.","journal-title":"Pediatr Pulmonol"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1023\/A:1018998028490","article-title":"Characterisation of aerosols of human recombinant deoxyribrose nuclease1 generated by jet nebulisers","volume":"2","author":"Cipolla, D.; Gonda, I.; Shire, S.J.","year":"1994","unstructured":"Cipolla D, Gonda I, Shire SJ. Characterisation of aerosols of human recombinant deoxyribrose nuclease1 generated by jet nebulisers. Pharm Res 1994;2:491\u20138.","journal-title":"Pharm Res"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1136\/adc.71.6.558-a","article-title":"Jet nebulising systems for recombinant human DNase 1","volume":"71","author":"Hung, J.C.C.; Hambleton, G.; Super, M.","year":"1994","unstructured":"Hung JCC, Hambleton G, Super M. Jet nebulising systems for recombinant human DNase 1. Arch Dis Child 1994; 71:558\u20139.","journal-title":"Arch Dis Child"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thx.52.2008.S64","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T17:09:47Z","timestamp":1711127387000},"score":1,"resource":{"primary":{"URL":"http:\/\/thorax.bmj.com\/cgi\/doi\/10.1136\/thx.52.2008.S64"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,4,1]]},"references-count":63,"journal-issue":{"issue":"Supplement 2","published-print":{"date-parts":[[1997,4,1]]}},"URL":"https:\/\/doi.org\/10.1136\/thx.52.2008.s64","relation":{},"ISSN":["0040-6376"],"issn-type":[{"value":"0040-6376","type":"print"}],"subject":[],"published":{"date-parts":[[1997,4,1]]}}}